Arthritis Drugs Archive | 2007

Arthritis Drugs

Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.


Arthritis Drugs - Issue: 34

Pfizer Urges MDL Court to Reject Purchaser Plaintiffs' 'Market' Theory

Read Full Article



Arthritis Drugs - Issue: 33

Federal Judge Certifies Investor Class in Celebrex Labeling Dispute

Read Full Article

Calif. Judge Designates Single Case for State's Next Vioxx Trial

Read Full Article

Judge: Staying State's Vioxx Suit Avoids Unnecessarily Prejudicing Merck

Read Full Article

Research Watch, Arthritis Drugs, February 2007

Read Full Article

N.J. Judge Orders Plaintiffs to Disclose Vioxx-Related Medical Records

Read Full Article

Pharmacy Says State Law Precludes Liability, Duty to Vioxx Plaintiff

Read Full Article

Plaintiff Can Pursue Claim that Physician Prescribed Excessive Vioxx Dose

Read Full Article




ISSUES BY YEAR




The HarrisMartin VerdicTrack



The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.